CONTACT:Richard WheltonHead / Director of Marketing, KUBTECrwhelton@kubtec.com(203) 364-8544 ext. 127 KUBTEC has been awarded a national group purchasing agreement for GammaPRO with Premier, Inc. Effective Jan 1, 2025., this new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for KUBTEC's GammaPRO gamma detection system. “This […]

Savvas Learning Company, a next-generation K-12 learning solutions leader, is pleased to announce that the Tennessee State Board of Education has approved its evidence-based, standards-aligned K-12 science programs for statewide adoption. https://mma.prnewswire.com/media/2603163/CorWeb581F1220JW2_PR_Assets_TN_K_12_Science.jpg Savvas science programs are aligned to the new Tennessee Academic Standards for Science, which require science curricula to be “academically rigorous, relevant to

The International Council for Commonality in Blood Banking Automation (“ICCBBA”), in partnership with the Italian national competent authority for blood Centro Nazionale Sangue (“CNS”) and for cells/tissues Centro Nazionale Trapianti (“CNT”), hosted Forum 30 The MPHO Safety and Traceability Summit on 14-15 November 2024. The event convened over 100 health professionals, patients, regulators, and other

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marqeta-inc-lawsuit-submission-form?prid=124382&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

(NASDAQ:VRSK), BOSTON, Jan. 22, 2025 (GLOBE NEWSWIRE) — The Extreme Event Solutions group at Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, estimates that insured industry losses to property for the Palisades and Eaton fires together will fall between USD 28 billion and USD 35 billion. This estimate includes losses due to

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Keros Therapeutics, Inc. ("Keros" or the "Company") (NASDAQ:KROS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Keros and certain of its officers and/or directors

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Macy’s, Inc. ("Macy’s" or "the Company") (NYSE:M) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=124379&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Warner Bros. Discovery, Inc. (NASDAQ:WBD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/warner-bros-discovery-lawsuit-submission-form?prid=124376&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com